Home / Resource Library / Study Reports Time-Limited Venetoclax-Based Regimens of Benefit in Front-Line Treatment of CLLStudy Reports Time-Limited Venetoclax-Based Regimens of Benefit in Front-Line Treatment of CLL EHA 2022